» Articles » PMID: 19955394

Inflammation and Cancer: Interweaving MicroRNA, Free Radical, Cytokine and P53 Pathways

Overview
Journal Carcinogenesis
Specialty Oncology
Date 2009 Dec 4
PMID 19955394
Citations 292
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic inflammation and infection are major causes of cancer. There are continued improvements to our understanding of the molecular connections between inflammation and cancer. Key mediators of inflammation-induced cancer include nuclear factor kappa B, reactive oxygen and nitrogen species, inflammatory cytokines, prostaglandins and specific microRNAs. The collective activity of these mediators is largely responsible for either a pro-tumorigenic or anti-tumorigenic inflammatory response through changes in cell proliferation, cell death, cellular senescence, DNA mutation rates, DNA methylation and angiogenesis. As our understanding grows, inflammatory mediators will provide opportunities to develop novel diagnostic and therapeutic strategies. In this review, we provide a general overview of the connection between inflammation, microRNAs and cancer and highlight how our improved understanding of these connections may provide novel preventive, diagnostic and therapeutic strategies to reduce the health burden of cancer.

Citing Articles

High-Grade Cervical Intraepithelial Neoplasia: Impact of Colposcopic Lesion Area on Systemic Immune Responses.

Mantoani P, Micheli D, Jammal M, Vieira J, Michelin M, Ferreira C Int J Womens Health. 2025; 17:345-353.

PMID: 39959756 PMC: 11827493. DOI: 10.2147/IJWH.S503028.


miRNA Signatures in Alveolar Macrophages Related to Cigarette Smoke: Assessment and Bioinformatics Analysis.

Mirra D, Esposito R, Spaziano G, Rafaniello C, Panico F, Squillante A Int J Mol Sci. 2025; 26(3).

PMID: 39941045 PMC: 11818525. DOI: 10.3390/ijms26031277.


Modulation of Intestinal Flora: a Novel Immunotherapeutic Approach for Enhancing Thyroid Cancer Treatment.

Huang W, Jiang T, He J, Ruan J, Wu B, Tao R Probiotics Antimicrob Proteins. 2025; .

PMID: 39890752 DOI: 10.1007/s12602-025-10471-z.


Plant miRNAs for Improved Gene Regulation in a Wide Range of Human Cancers.

Zoziuk M, Colizzi V, Krysenko P, Mattei M, Bernardini R, Zanzotto F Curr Issues Mol Biol. 2025; 47(1).

PMID: 39852157 PMC: 11763636. DOI: 10.3390/cimb47010042.


Application of targeted drug delivery by cell membrane-based biomimetic nanoparticles for inflammatory diseases and cancers.

Qiu S, Zhu F, Tong L Eur J Med Res. 2024; 29(1):523.

PMID: 39472940 PMC: 11523786. DOI: 10.1186/s40001-024-02124-8.


References
1.
Cacev T, Radosevic S, Krizanac S, Kapitanovic S . Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. Carcinogenesis. 2008; 29(8):1572-80. DOI: 10.1093/carcin/bgn164. View

2.
Lu L, Liston A . MicroRNA in the immune system, microRNA as an immune system. Immunology. 2009; 127(3):291-8. PMC: 2712098. DOI: 10.1111/j.1365-2567.2009.03092.x. View

3.
Watanapa P, Watanapa W . Liver fluke-associated cholangiocarcinoma. Br J Surg. 2002; 89(8):962-70. DOI: 10.1046/j.1365-2168.2002.02143.x. View

4.
Gupta R, DuBois R . Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer. 2002; 1(1):11-21. DOI: 10.1038/35094017. View

5.
Mayne S, Buenconsejo J, Janerich D . Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol. 1999; 149(1):13-20. DOI: 10.1093/oxfordjournals.aje.a009722. View